Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- 1.6 BIOLOGICAL SCIENCES (1)
- 3.3 HEALTH SCIENCES (1)
- 3.5 OTHER MEDICAL SCIENCES (1)
- 4.3 VETERINARY SCIENCE (1)
- 4.4 AGRICULTURAL BIOTECHNOLOGY (1)
-
- Anti-TB (1)
- Antibacterial agent (1)
- Antibiotic (1)
- Assay (1)
- Biochemistry and molecular biology (1)
- Biology (1)
- Cell biology, (1)
- Cystic fibrosis (1)
- Drug delivery (1)
- Drug susceptibility (1)
- Green chemistry (1)
- Infectious diseases (1)
- Microbiology (1)
- Mycobacteriophages (1)
- Mycobacterium smegmatis (1)
- Nanomaterials (1)
- Optimization study (1)
- Pharrnacogenomics (1)
- Proteins and enzymes and how they influence (1)
- Pseudomonas aeruginosa (1)
- Superparamagnetic iron oxide nanoparticles (SPIONS) (1)
- Publication
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Pathogenic Microbiology
A Rapid Viability And Drug‑Susceptibility Assay Utilizing Mycobacteriophage As An Indicator Of Drug Susceptibilities Of Anti‑Tb Drugs Against Mycobacterium Smegmatis Mc2 155, Gillian Catherine Crowley, Jim O'Mahony, Aidan Coffey, Riona G. Sayers, Paul D. Cotter
A Rapid Viability And Drug‑Susceptibility Assay Utilizing Mycobacteriophage As An Indicator Of Drug Susceptibilities Of Anti‑Tb Drugs Against Mycobacterium Smegmatis Mc2 155, Gillian Catherine Crowley, Jim O'Mahony, Aidan Coffey, Riona G. Sayers, Paul D. Cotter
Department of Biological Sciences Publications
Background: A rapid in-house TM4 mycobacteriophage-based assay, to identify multidrug resistance against various anti-tuberculosis drugs, using the fast-growing Mycobacterium smegmatis mc2 155 in a microtiter plate format was evaluated, based on phage viability assays. Methods: A variety of parameters were optimized before the study including the minimum incubation time for the drugs, phage and M. smegmatis mc2 155 to be in contact. An increase in phage numbers over 2 h was indicative that M. smegmatis mc2 155 is resistant to the drugs under investigation, however when phage numbers remained static, M. smegmatis mc2 155 found to …
Iron-Containing Nanoparticles For The Treatment Of Chrionic Biofilm Infections In Cystic Fibrosis, Leisha M. A. Martin
Iron-Containing Nanoparticles For The Treatment Of Chrionic Biofilm Infections In Cystic Fibrosis, Leisha M. A. Martin
Nanoscience and Microsystems ETDs
Cystic fibrosis (CF) is the most common genetic disease resulting in the morbidity and mortality of Caucasian children and adults worldwide. Due to a genetic mutation resulting in malfunction of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, CF patients produce highly viscous mucus in their respiratory tract. This leads to impairment of the mucociliary clearance of inhaled microbes. In addition to reduced microbial clearance, anoxic environmental conditions in the lungs promote biofilm-mode growth of the pathogenic bacterial species Pseudomonas aeruginosa. Chronic infections of P. aeruginosa begin in early childhood and typically persist until respiratory failure and death result. The …